Ticker Details
Korro Bio, Inc.
IPO Date:	October 4, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$104.63M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.93 | 4.39%
Avg Daily Range (30 D):	$0.31 | 2.81%
Avg Daily Range (90 D):	$0.79 | 3.93%

Institutional Daily Volume
Avg Daily Volume:	.33M
Avg Daily Volume (30 D):	.23M
Avg Daily Volume (90 D):	.4M

Trade Size
Avg Trade Size (Sh.):	132
Avg Trade Size (Sh.) (30 D):	77
Avg Trade Size (Sh.) (90 D):	87

Institutional Trades
Total Institutional Trades:	312
Avg Institutional Trade:	$1.87M
Avg Institutional Trade (30 D):	$1.77M
Avg Institutional Trade (90 D):	$1.33M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.47M
Avg Closing Trade (30 D):	$.69M
Avg Closing Trade (90 D):	$.79M
Avg Closing Volume:	124.62K

News

Jan 8, 2026 @ 1:00 PM Korro to Present at the 44th Annual J.P. Morgan He... Source: Na

Mar 14, 2025 @ 12:00 PM KRRO-110 Receives Orphan Drug Designation from U.S... Source: N/A

Nov 8, 2024 @ 7:34 AM 4 Biotech Stocks With AI, Machine Learning Prowess... Source: Professor Ari Zoldan

Sep 19, 2024 @ 10:50 AM Novo Nordisk Just Took a $530 Million Step Onto Mo... Source: The Motley Fool

May 20, 2024 @ 6:30 PM Korro Presents Additional Preclinical Data for KRR... Source: Korro Bio, Inc.

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-9.42	$-1.92	$-2.74
Diluted EPS	$-9.42	$-1.92	$-2.74
Revenue	$7.37M	$1.09M	$1.46M
Gross Profit
Net Income / Loss	$-88.42M	$-18.06M	$-25.77M
Operating Income / Loss	$-94.5M	$-19.24M	$-27.2M
Cost of Revenue
Net Cash Flow	$-40.82M	$-9.46M	$-30.53M
PE Ratio